Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Magnetic Sentinel Lymph Node Biopsy in Early Breast Cancer Patients: An Individual Patient Data Meta-analysis of Tracer Uptake.
Christenhusz A, Mirzaei N, Karakatsanis A, Eriksson S, Wärnberg F, Olofsson Bagge R, van der Palen J, Simanowski J, Salamzadeh S, Ten Haken B, Dassen AE, Alic L. Christenhusz A, et al. Among authors: karakatsanis a. Ann Surg Oncol. 2024 Dec 17. doi: 10.1245/s10434-024-16626-6. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39690385
The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies.
Karakatsanis A, Christiansen PM, Fischer L, Hedin C, Pistioli L, Sund M, Rasmussen NR, Jørnsgård H, Tegnelius D, Eriksson S, Daskalakis K, Wärnberg F, Markopoulos CJ, Bergkvist L. Karakatsanis A, et al. Breast Cancer Res Treat. 2016 Jun;157(2):281-294. doi: 10.1007/s10549-016-3809-9. Epub 2016 Apr 27. Breast Cancer Res Treat. 2016. PMID: 27117158 Free PMC article. Clinical Trial.
Simplifying Logistics and Avoiding the Unnecessary in Patients With Breast Cancer Undergoing Sentinel Node Biopsy. A Prospective Feasibility Trial of the Preoperative Injection of Super Paramagnetic Iron Oxide Nanoparticles.
Karakatsanis A, Olofsson H, Stålberg P, Bergkvist L, Abdsaleh S, Wärnberg F. Karakatsanis A, et al. Scand J Surg. 2018 Jun;107(2):130-137. doi: 10.1177/1457496917738867. Epub 2017 Nov 13. Scand J Surg. 2018. PMID: 29132268 Clinical Trial.
A combined, totally magnetic technique with a magnetic marker for non-palpable tumour localization and superparamagnetic iron oxide nanoparticles for sentinel lymph node detection in breast cancer surgery.
Hersi AF, Eriksson S, Ramos J, Abdsaleh S, Wärnberg F, Karakatsanis A. Hersi AF, et al. Among authors: karakatsanis a. Eur J Surg Oncol. 2019 Apr;45(4):544-549. doi: 10.1016/j.ejso.2018.10.064. Epub 2018 Oct 23. Eur J Surg Oncol. 2019. PMID: 30401506
Long-Term Outcome After Retro-Areolar Versus Peri-Tumoral Injection of Superparamagnetic Iron Oxide Nanoparticles (SPIO) for Sentinel Lymph Node Detection in Breast Cancer Surgery.
Wärnberg F, Stigberg E, Obondo C, Olofsson H, Abdsaleh S, Wärnberg M, Karakatsanis A. Wärnberg F, et al. Among authors: karakatsanis a. Ann Surg Oncol. 2019 May;26(5):1247-1253. doi: 10.1245/s10434-019-07239-5. Epub 2019 Mar 4. Ann Surg Oncol. 2019. PMID: 30830536 Free PMC article.
Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal carcinoma in situ (SentiNot study).
Karakatsanis A, Hersi AF, Pistiolis L, Olofsson Bagge R, Lykoudis PM, Eriksson S, Wärnberg F; SentiNot Trialists Group. Karakatsanis A, et al. Br J Surg. 2019 May;106(6):720-728. doi: 10.1002/bjs.11110. Epub 2019 Mar 6. Br J Surg. 2019. PMID: 30839104 Clinical Trial.
109 results